Dual Use: The Worst of Both Worlds, or a Step in the Right Direction?
Millions of people both smoke and vape. Public health orthodoxy treats dual use as a failure—but emerging evidence suggests it might be a transitional state leading to eventual cessation. The data tells a more complex story.
The dual user is public health's problem child. They haven't quit smoking, which means they're still exposed to the carcinogens and toxicants from combustible tobacco. They're also vaping, which means they're exposed to whatever risks e-cigarette aerosol carries. On paper, they've adopted the worst of both worlds—adding a new exposure without eliminating the old one. And there are millions of them. In the United States, roughly 40% of adult vapers also smoke, a proportion that has remained stubbornly consistent even as overall smoking rates have declined. The standard public health interpretation of dual use is that it represents a failure of vaping as a cessation tool—smokers are supplementing rather than substituting, maintaining their addiction on two fronts. But the longitudinal data tells a story that's more interesting, more hopeful, and more relevant to policy than the cross-sectional snapshot suggests.
When you follow dual users over time, a clear pattern emerges: they're more likely to quit smoking than exclusive smokers, and they're more likely to transition to exclusive vaping than exclusive smokers are to take up vaping from scratch. A 2023 analysis of the Population Assessment of Tobacco and Health (PATH) study, which tracks a nationally representative sample of U.S. tobacco users over multiple years, found that dual users at baseline were roughly twice as likely to have quit smoking at follow-up compared to exclusive smokers. They were also significantly more likely to have reduced their cigarette consumption by 50% or more. The dual-use state, for many smokers, is not a permanent equilibrium. It's a way station—a period of experimentation and partial substitution that, for a substantial minority, resolves into either complete switching or complete cessation.
The mechanism is intuitive once you think about smoking not as a binary state (smoker/non-smoker) but as a behavioral repertoire that changes incrementally. A smoker who starts vaping typically doesn't wake up one morning and switch completely. They vape in situations where smoking is inconvenient or prohibited—at work, at home with family, in the car—while continuing to smoke in situations where the ritual is deeply ingrained: with morning coffee, after meals, during stress. Over time, the proportion of nicotine obtained from vaping increases and the proportion from smoking decreases. Some smokers reach 100% substitution. Others stabilize at partial substitution. A minority return to exclusive smoking. The point is that dual use is not a stable category—it's a dynamic state, and the direction of movement, for most dual users, is toward less smoking over time.
The most hopeful data on dual use comes from the UK, where the policy environment actively encourages complete switching. The UK's National Health Service explicitly advises dual users that 'every cigarette you don't smoke is a victory' and that 'switching completely is the goal, but reducing is a step in the right direction.' This messaging, combined with access to higher-quality vaping products through the 'swap to stop' program and clear communication that vaping is substantially less harmful than smoking, has been associated with declining dual use rates—because more dual users are completing the transition. The UK experience suggests that dual use is not an inherent failure mode of vaping but a consequence of how it's regulated and communicated. When the policy environment treats partial substitution as progress rather than failure, more smokers complete the substitution.
The alternative interpretation—that dual use should be discouraged because it maintains smoking—rests on the assumption that dual users would have quit entirely without vaping. This assumption is almost certainly false for most dual users. The smokers who take up vaping are disproportionately those who have tried and failed to quit using other methods, often multiple times. They are not choosing between vaping and quitting; they are choosing between vaping and continued exclusive smoking. Framing dual use as a public health failure implicitly compares it to an idealized counterfactual—'if only they'd quit entirely'—rather than to the realistic baseline of continued smoking. When you compare dual use to continued exclusive smoking, the dual user is reducing their exposure to combustion toxicants, reducing their cigarette consumption, and statistically more likely to eventually quit. That's not failure. That's harm reduction in slow motion.
The clinical implications are significant. Currently, many smoking cessation programs and healthcare providers treat dual use as a negative outcome and encourage dual users to quit vaping as well as smoking—effectively asking them to surrender the tool that's helping them reduce their smoking. A harm-reduction-informed approach would instead encourage dual users to identify the cigarettes they haven't yet replaced—the morning coffee cigarette, the stress cigarette—and develop strategies for substituting those as well. The goal is not to add vaping to smoking permanently. It's to use vaping to eliminate smoking incrementally. This approach requires a different kind of clinical conversation: one that acknowledges the reality of partial progress, celebrates reduction as well as cessation, and provides practical support for completing the transition. It's more work than a binary 'quit or don't' framework. It's also more effective.
Dual use is not a policy goal. No one should be satisfied with a world where millions of people both smoke and vape indefinitely. But dual use is a transitional reality for a large proportion of smokers who are trying to quit, and treating it as a failure to be condemned rather than a process to be supported has real consequences. It drives smokers away from the tools that could help them quit, reinforces the misperception that vaping and smoking are equally harmful (if they were, why switch at all?), and misses the opportunity to engage dual users at a moment when they're actively trying to change their behavior. The public health community has gotten very good at telling smokers to quit. It's been less good at providing the practical, non-judgmental support that helps them succeed. Dual users, poised between addiction and cessation, are the smokers most ready to be helped. The question is whether we'll meet them where they are.












